Abstracts submissions close Thursday 11:59pm, 11 March 2027. Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Search

Hanlim Pharmaceutical is a leading Korean pharmaceutical company committed to improving patients’ lives through innovative therapies. Through its specialized Immunology Division, Hanlim focuses on advancing care for patients with immune-mediated and rheumatic diseases, fostering scientific collaboration and delivering high-quality treatment solutions that improve patient outcomes and quality of life.

Share

Key dates

Registrations
Abstracts

More Partners / Exhibitors

CESAS Medical
Novartis
Association of Women in Rheumatology
Samil Pharmaceutical Co., Ltd.
Samsung Bioepis
Dong-A ST
Days
Hours
Minutes
Seconds

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.